144 related articles for article (PubMed ID: 38094439)
1. Retracted: Identification of Novel Biomarkers Related to Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9780526. PubMed ID: 38094439
[TBL] [Abstract][Full Text] [Related]
2. Retracted: Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients-An Integrated Bioinformatics Approach.
Markers D
Dis Markers; 2023; 2023():9836354. PubMed ID: 37744889
[TBL] [Abstract][Full Text] [Related]
3. Retracted: Implications of Human Antimicrobial Peptide Defensin Beta-1 in Clinical Oral Squamous Cell Carcinoma Patients via an Integrated Bioinformatics Approach.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9820871. PubMed ID: 38094444
[TBL] [Abstract][Full Text] [Related]
4. Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9819147. PubMed ID: 37808149
[TBL] [Abstract][Full Text] [Related]
5. Retracted: Bioinformatics Analysis of mRNAs and miRNAs for Identifying Potential Biomarkers in Lung Adenosquamous Carcinoma.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9805413. PubMed ID: 38094407
[TBL] [Abstract][Full Text] [Related]
6. Retracted: Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma.
Markers D
Dis Markers; 2023; 2023():9893453. PubMed ID: 37387739
[TBL] [Abstract][Full Text] [Related]
7. Retracted: Comprehensive and Integrated Analysis Identifies ZEB1 as a Key Novel Gene in Oral Squamous Cell Carcinoma.
Imaging CMM
Contrast Media Mol Imaging; 2023; 2023():9783040. PubMed ID: 37502536
[TBL] [Abstract][Full Text] [Related]
8. Retracted: Hub Genes and Long Noncoding RNAs That Regulates It Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9780394. PubMed ID: 38124946
[TBL] [Abstract][Full Text] [Related]
9. Retracted: Identification of Molecular Biomarkers and Key Pathways for Esophageal Carcinoma (EsC): A Bioinformatics Approach.
International BR
Biomed Res Int; 2024; 2024():9878069. PubMed ID: 38230060
[TBL] [Abstract][Full Text] [Related]
10. Retracted: Identification of Differentially Expressed Long Noncoding RNAs as Functional Biomarkers and Construction of Function Enrichment Network in Oral Squamous Cell Carcinoma.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9820845. PubMed ID: 37565232
[TBL] [Abstract][Full Text] [Related]
11. Retracted: Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network.
Markers D
Dis Markers; 2023; 2023():9841329. PubMed ID: 37538089
[TBL] [Abstract][Full Text] [Related]
12. Retracted: Identification of Paxillin as a Prognostic Factor for Glioblastoma via Integrated Bioinformatics Analysis.
International BR
Biomed Res Int; 2023; 2023():9762109. PubMed ID: 38075323
[TBL] [Abstract][Full Text] [Related]
13. Retracted: Integrated Bioinformatics Analysis for Identification of the Hub Genes Linked with Prognosis of Ovarian Cancer Patients.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9826839. PubMed ID: 38094343
[TBL] [Abstract][Full Text] [Related]
14. Retracted: Identification of Key Genes in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
Intelligence And Neuroscience C
Comput Intell Neurosci; 2023; 2023():9836790. PubMed ID: 38074350
[TBL] [Abstract][Full Text] [Related]
15. Retracted: Hub Gene Screening and Prognostic Modeling of Lung Cancer: An Integrated Bioinformatics Study.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9834087. PubMed ID: 37475946
[TBL] [Abstract][Full Text] [Related]
16. Retracted: Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis.
International BR
Biomed Res Int; 2024; 2024():9784513. PubMed ID: 38230025
[TBL] [Abstract][Full Text] [Related]
17. Retracted: Identification and Validation of Potential Biomarkers and Pathways for Idiopathic Pulmonary Fibrosis by Comprehensive Bioinformatics Analysis.
International BR
Biomed Res Int; 2024; 2024():9848271. PubMed ID: 38550096
[TBL] [Abstract][Full Text] [Related]
18. Retracted: Identification of Potential Key Genes and Molecular Mechanisms of Medulloblastoma Based on Integrated Bioinformatics Approach.
International BR
Biomed Res Int; 2024; 2024():9853643. PubMed ID: 38550031
[TBL] [Abstract][Full Text] [Related]
19. Retracted: An Immune-Related Genetic Feature Depicted the Heterogeneous Nature of Lung Adenocarcinoma and Squamous Cell Carcinoma and Their Distinctive Predicted Drug Responses.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9823238. PubMed ID: 37593686
[TBL] [Abstract][Full Text] [Related]
20. Retracted: miR-223-5p Suppresses OTX1 to Mediate Malignant Progression of Lung Squamous Cell Carcinoma Cells.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9792368. PubMed ID: 37811209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
